Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)

Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)

Scope of the Report

The report entitled “Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)”, provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments.

The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competitive landscape, key competitors in the market have been compared on the basis of share.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.

Company Coverage

Abbvie Inc
Samsung Electronics (Samsung Biologics)
F.Hoffmann La Roche
Amgen Inc.

Regional Coverage

North America
South America
Europe (Western and Eastern Europe)
Asia Pacific (China)
Middle East and Africa

Executive Summary

Pharmaceutical industry is engaged in the discovery, manufacturing and marketing of pharmaceutical drugs such as legal drugs, vaccines, biologics and a large number of medical devices such as infusion pump, pacemakers, prosthetics, implantable defibrillators etc. Pharmaceutical drugs and devices are subjected to various laws and regulations governing their patent, safety, and efficacy. On an elementary level pharmaceutical drugs are broadly classified into two categories: small molecules (non-biologics) and large molecules (biologics).

Large molecules are mostly made of cells or other living organisms and are used to produce therapeutic proteins or biological molecules. Drugs made up of large molecules are popularly known as biotech drugs, biologics or biopharmaceuticals. The major biologics blockbusters currently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin.

The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2019-2023. The market is supported by various growth drivers such as rise in sedentary lifestyle, hike in spending on healthcare, increasing biologics approval, growing incidence of chronic conditions among the aging population, increased availability of advanced diagnostics, rising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases and advancement in healthcare & biotechnology.

Yet the market faces some restraints which are obstructing the growth of the market. Some of the major challenges faced by the industry are emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges.


1. Executive Summary
2. Introduction
2.1 Pharmaceutical Industry: An Overview
Table 1: History of Pharmaceutical Industry
2.1.1 Segmentation of Pharmaceutical Industry (Drugs)
Table 2: Pharmaceutical Industry Segments
2.2 Biologics: An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Use
2.2.3 Difference between Chemical Drugs and Biologics
Table 3: Chemical Drugs vs. Biologics
2.2.4 Key Biologics Product US/EU Expiry Date
Table 4: Key Biologics Product US/EU Expiry Date
2.3 Biologics Manufacturing Process
2.3.1 Biologics Manufacturing Process
Table 5: Biologics Manufacturing Process
2.4 Biologics Product-Category
2.4.1 Biologics Product-Category
Table 6: Biologics Product-Category
3. Global Market Analysis
3.1 Global Pharmaceuticals Market Analysis
3.1.1 Global Pharmaceuticals Market by Value
Table 7: Global Pharmaceuticals Market by Value; 2014-2018 (US$ Billion)
Table 8: Global Pharmaceuticals Market by Value; 2019-2023 (US$ Billion)
3.1.2 Global Pharmaceuticals Market by Segments
Table 9: Global Pharmaceuticals Market by Segments; 2018 (Percentage,%)
3.2 Global Biologics Market Analysis
3.2.1 Global Biologics Market by Value
Table 10: Global Biologics Market by Value; 2014-2018 (US$ Billion)
Table 11: Global Biologics Market by Value; 2019-2023 (US$ Billion)
3.2.2 Global Biologics Manufacturing Market by Value
Table 12: Global Biologics Manufacturing Market by Value; 2015-2018 (US$ Billion)
Table 13: Global Biologics Manufacturing Market by Value; 2019-2023 (US$ Billion)
3.2.3 Global Biologics Manufacturing Market by Segments
Table 14: Global Biologics Manufacturing Market by Segments; 2018 (Percentage,%)
3.2.4 Global Biologics In-House Market by Value
Table 15: Global Biologics In-House Market by Value; 2015-2018 (US$ Billion)
Table 16: Global Biologics In-House Market by Value; 2019-2023 (US$ Billion)
3.2.5 Global Bio CMO Market by Value
Table 17: Global Bio CMO Market by Value; 2014-2018 (US$ Billion)
Table 18: Global Bio CMO Market by Value; 2019-2023 (US$ Billion)
3.3 Global Biologics Market Product Analysis
3.3.1 Global Biologics Market by Product-Category
Table 19: Global Biologics Market by Product-Category; 2018 (Percentage,%)
3.3.2 Global Biologics Monoclonal Antibodies Market by Value
Table 20: Global Biologics Monoclonal Antibodies Market by Value; 2015-2018 (US$ Billion)
Table 21: Global Biologics Monoclonal Antibodies Market by Value; 2019-2023 (US$ Billion)
3.3.3 Global Biologics Recombinant Protein Market by Value
Table 22: Global Biologics Recombinant Protein Market by Value; 2015-2018 (US$ Billion)
Table 23: Global Biologics Recombinant Protein Market by Value; 2019-2023 (US$ Billion)
3.3.4 Global Biologics Vaccines Market by Value
Table 24: Global Biologics Vaccines Market by Value; 2015-2018 (US$ Billion)
Table 25: Global Biologics Vaccines Market by Value; 2019-2023 (US$ Billion)
3.3.5 Global Biologics Regenerative Medicines Market by Value
Table 26: Global Biologics Regenerative Medicine Market by Value; 2015-2018 (US$ Billion)
Table 27: Global Biologics Regenerative Medicine Market by Value; 2019-2023 (US$ Billion)
3.4 Global Biologics Market Therapeutic Area Analysis
3.4.1 Global Biologics Market by Therapeutic Areas
Table 28: Global Biologics Market by Therapeutic Areas; 2018 (Percentage,%)
3.4.2 Global Inflammatory Diseases Biologics Market by Value
Table 29: Global Inflammatory Diseases Biologics Market by Value; 2015-2018 (US$ Billion)
Table 30: Global Inflammatory Diseases Biologics Market by Value; 2019-2023 (US$ Billion)
3.4.3 Global Oncology and Immunomodulatory Biologics Market by Value
Table 31: Global Oncology and Immunomodulatory Biologics Market by Value; 2015-2018 (US$ Billion)
Table 32: Global Oncology and Immunomodulatory Biologics Market by Value; 2019-2023 (US$ Billion)
3.4.4 Global Endocrine Disorders Biologics Market by Value
Table 33: Global Endocrine Disorders Market by Value; 2015-2018 (US$ Billion)
Table 34: Global Endocrine Disorders Market by Value; 2019-2023 (US$ Billion)
3.4.5 Global Anti-Infectives Biologics Market by Value
Table 35: Global Anti-Infectives Biologics Market by Value; 2015-2018 (US$ Billion)
Table 36: Global Biologics Anti-Infectives Market by Value; 2019-2023 (US$ Billion)
3.5 Global Biologics Market Regional Analysis
3.5.1 Global Biologics Market by Region
Table 37: Global Biologics Market by Region; 2018 (Percentage,%)
4. Regional Analysis
4.1 North America Biologics Market Analysis
4.1.1 North America Biologics Market by Value
Table 38: North America Biologics Market by Value; 2016-2018 (US$ Billion)
Table 39: North America Biologics Market by Value; 2019-2023 (US$ Billion)
4.2 South America Biologics Market Analysis
4.2.1 South America Biologics Market by Value
Table 40: South America Biologics Market by Value; 2014-2018 (US$ Billion)
Table 41: South America Biologics Market by Value; 2019-2023 (US$ Billion)
4.3 Europe Biologics Market Analysis
4.3.1 Europe Biologics Market by Value
Table 42: Europe Biologics Market by Value; 2016-2018 (US$ Billion)
Table 43: Europe Biologics Market by Value; 2019-2023 (US$ Billion)
4.3.2 Europe Biologics Market by Region
Table 44: Europe Biologics Market by Region; 2018 (Percentage,%)
4.3.3 Western Europe Biologics Market by Value
Table 45: Western Europe Biologics Market by Value; 2016-2018 (US$ Billion)
Table 46: Western Europe Biologics Market by Value; 2019-2023 (US$ Billion)
4.3.4 Eastern Europe Biologics Market by Value
Table 47: Eastern Europe Biologics Market by Value; 2016-2018 (US$ Billion)
Table 48: Eastern Europe Biologics Market by Value; 2019-2023 (US$ Billion)
4.4 Asia Pacific Biologics Market Analysis
4.4.1 Asia Pacific Biologics Market by Value
Table 49: Asia Pacific Biologics Market by Value; 2016-2018 (US$ Billion)
Table 50: Asia Pacific Biologics Market by Value; 2019-2023 (US$ Billion)
4.4.2 Asia Pacific Biologics Market by Countries
Table 51: Asia Pacific Biologics Market by Countries; 2018 (Percentage,%)
4.4.3 China Biologics Market by Value
Table 52: China Biologics Market by Value; 2014-2018 (US$ Billion)
Table 53: China Biologics Market by Value; 2019-2023 (US$ Billion)
4.5 Middle East and Africa Biologics Market Analysis
4.5.1 Middle East and Africa Biologics Market by Value
Table 54: Middle East and Africa Biologics Market by Value; 2016-2018 (US$ Billion)
Table 55: Middle East and Africa Biologics Market by Value; 2019-2023 (US$ Billion)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rise in Sedentary Lifestyle
5.1.2 Hike in Spending on Healthcare
5.1.3 Elevation in Biologics Approvals
Table 56: Biologics as a Percentage of Total Drug Approvals;2012-2018
5.1.4 Rising Autoimmune Disease Prevalence
Table 57: Prevalence of Diagnosed Autoimmune Conditions; 2018
5.1.5 Preference of Biologics Over Small Molecules
Table 58: Global Biopharmaceuticals (Drugs) Market by Segments;2006-2020
5.2 Challenges
5.2.1 Growing Number of Biosimilars
Table 59: Major Biologics Patent Expiration between 2015-2025E
5.2.2 Lack of Oral Absorption
5.2.3 Operational and Technological Challenges
5.2.4 High Cost
5.3 Market Trends
5.3.1 Spike in Mergers and Acquisitions (M&A) Activity
5.3.2 Demand of Biologics in the Treatment of Complex Diseases
5.3.3 Biologics for the Treating of Dermatological Conditions
5.3.4 Advancement in Healthcare and Biotechnology
5.3.5 Commercial Success of Biotech Products
5.3.6 Reimbursement Policy
6. Competitive Landscape
6.1 Global Biologics Market Players Analysis
6.1.1 Global Biologics Market Players by Share
Table 60: Global Biologics Market Players by Share; 2018
Table 61: Global Biologics Market Key Competitors Share; 2018
6.2 Global Biologics Market Players/Drugs
Table 62: Global Biologics Market by Players/Drugs; 2018
7. Company Profiles
7.1 Abbvie Inc.
7.1.1 Business Overview
Table 63: HUMIRA Principal Markets
7.1.2 Financial Overview
Table 64: Abbvie Inc. Sales; 2014-2018 (US$ Billion)
Table 65: Abbvie Inc. Sales by Product; 2018
Table 66: Abbvie Inc. Sales by Geography; 2018
7.1.3 Business Strategy
7.2 Samsung Electronics (Samsung Biologics)
7.2.1 Business Overview
7.2.2 Financial Overview
Table 67: Samsung BioLogics Revenue; 2014-2018 (US$ Million)
7.2.3 Business Strategy
7.3 F. Hoffmann La Roche
7.3.1 Business Overview
7.3.2 Financial Overview
Table 68: F. Hoffmann-La Roche Sales; 2014-2018 (US$ Billion)
Table 69: F. Hoffmann-La Roche Sales by Segments; 2018
Table 70: F. Hoffmann-La Roche Sales by Region; 2018
7.3.3 Business Strategy
7.4 Amgen Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
Table 71: Amgen Total Revenue; 2018-2014 (US$ Billion)
Table 72: Amgen Total Revenue by Products; 2018
Table 73: Amgen Total Revenue by Region; 2018
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook